Literature DB >> 7476309

Metabolic effects of growth hormone in humans.

N Møller1, J O Jørgensen, J Møller, L Orskov, P Ovesen, O Schmitz, J S Christiansen, H Orskov.   

Abstract

Growth hormone (GH) has acute actions to stimulate lipolysis and ketogenesis after 2 to 3 hours, effects that may be important in the adaptation to stress and fasting. This is accompanied by a decrease in insulin sensitivity in both liver and muscle. These combined effects may be very deleterious to insulin-dependent diabetic patients, in whom increased GH secretion may precipitate and maintain acute metabolic derangement (ketoacidosis) and be a major initiator of the dawn phenomenon. On the other hand, augmented GH secretion plays a beneficial role in the defense against hypoglycemia, in particular during prolonged hypoglycemia and in patients with impaired ability to secrete other counterregulatory hormones appropriately. It is also certain that GH is a potent anabolic hormone in terms of promoted nitrogen retention, but the extent to which these well-known actions are direct or secondary to hyperinsulinemia, increased activity of insulin-like growth factors (IGFs), or release of protein-conserving lipid intermediates has eluded precise characterization.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7476309     DOI: 10.1016/0026-0495(95)90218-x

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  8 in total

Review 1.  Energy Metabolism Profile in Individuals with Prader-Willi Syndrome and Implications for Clinical Management: A Systematic Review.

Authors:  Maha Alsaif; Sarah A Elliot; Michelle L MacKenzie; Carla M Prado; Catherine J Field; Andrea M Haqq
Journal:  Adv Nutr       Date:  2017-11-15       Impact factor: 8.701

Review 2.  Membrane glycoprotein PC-1 and insulin resistance.

Authors:  I D Goldfine; B A Maddux; J F Youngren; L Frittitta; V Trischitta; G L Dohm
Journal:  Mol Cell Biochem       Date:  1998-05       Impact factor: 3.396

3.  Diabetogenic role of insulin's counterregulatory hormones in the isletectomized, diabetic goby.

Authors:  J T Haigwood; R M Flores; R Mazloumi; G Ngan; K M Kelley
Journal:  Endocrine       Date:  2000-12       Impact factor: 3.633

Review 4.  Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes?

Authors:  M J Rennie
Journal:  Br J Sports Med       Date:  2003-04       Impact factor: 13.800

5.  Reduced abdominal adiposity and improved glucose tolerance in growth hormone-treated girls with Turner syndrome.

Authors:  Nicole Wooten; Vladimir K Bakalov; Suvimol Hill; Carolyn A Bondy
Journal:  J Clin Endocrinol Metab       Date:  2008-03-18       Impact factor: 5.958

Review 6.  Growth hormone, IGF-I and insulin and their abuse in sport.

Authors:  R I G Holt; P H Sönksen
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

7.  The effect of training volume and intensity on improvements in muscular strength and size in resistance-trained men.

Authors:  Gerald T Mangine; Jay R Hoffman; Adam M Gonzalez; Jeremy R Townsend; Adam J Wells; Adam R Jajtner; Kyle S Beyer; Carleigh H Boone; Amelia A Miramonti; Ran Wang; Michael B LaMonica; David H Fukuda; Nicholas A Ratamess; Jeffrey R Stout
Journal:  Physiol Rep       Date:  2015-08

8.  Loss of Adipocyte STAT5 Confers Increased Depot-Specific Adiposity in Male and Female Mice That Is Not Associated With Altered Adipose Tissue Lipolysis.

Authors:  Allison J Richard; Hardy Hang; Timothy D Allerton; Peng Zhao; Tamra Mendoza; Sujoy Ghosh; Carrie M Elks; Jacqueline M Stephens
Journal:  Front Endocrinol (Lausanne)       Date:  2022-04-07       Impact factor: 6.055

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.